Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00072852
Recruitment Status : Completed
First Posted : November 13, 2003
Last Update Posted : October 16, 2008
Sponsor:
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2007
Actual Study Completion Date : May 2007